CVR Medical (STU:B3BN) Market Cap: €1.52 Mil (As of Aug. 02, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is CVR Medical Market Cap?

CVR Medical STU:B3BN Market Cap is €1.52 Mil as of Aug. 02, 2026.

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). CVR Medical's share price for the quarter that ended in Sep. 2022 was €0.0135. CVR Medical's Shares Outstanding (EOP) for the quarter that ended in Sep. 2022 was 107.23 Mil. Therefore, CVR Medical's market cap for the quarter that ended in Sep. 2022 was €1.45 Mil.

CVR Medical's quarterly market cap increased from Mar. 2022 (€1.42 Mil) to Jun. 2022 (€1.45 Mil) but then stayed the same from Jun. 2022 (€1.45 Mil) to Sep. 2022 (€1.45 Mil).

CVR Medical's annual market cap increased from Dec. 2019 (€0.00 Mil) to Dec. 2020 (€1.37 Mil) and increased from Dec. 2020 (€1.37 Mil) to Dec. 2021 (€1.42 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. CVR Medical's Enterprise Value for Today is €2.29 Mil.


CVR Medical  (STU:B3BN) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


CVR Medical Market Cap Related Terms


CVR Medical Market Cap Historical Data

* Premium members only.

The historical data trend for CVR Medical's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CVR Medical Market Cap Chart

CVR Medical Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 1.37 1.42

CVR Medical Quarterly Data
Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.37 1.42 1.42 1.45 1.45

STU:B3BN vs NNMX, LHDXQ, VIVE: Market Cap Comparison

For the Medical Devices subindustry, CVR Medical's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CVR Medical Market Cap vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, CVR Medical's Market Cap distribution charts can be found below:

* The bar in red indicates where CVR Medical's Market Cap falls into.



CVR Medical Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

CVR Medical's Market Cap for the fiscal year that ended in Dec. 2021 is calculated as

Market Cap (A: Dec. 2021 )=Share Price (A: Dec. 2021 )*Shares Outstanding (EOP) (A: Dec. 2021 )
=€0.0135*105.228
=€1.42

CVR Medical's Market Cap for the quarter that ended in Sep. 2022 is calculated as

Market Cap (Q: Sep. 2022 )=Share Price (Q: Sep. 2022 )*Shares Outstanding (EOP) (Q: Sep. 2022 )
=€0.0135*107.233
=€1.45

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Market Cap →
What does a Market Cap of €1.52 Mil mean?
CVR Medical (STU:B3BN) has a Market Cap of €1.52 Mil as of Aug. 02, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on CVR Medical and its competitors.
Is CVR Medical's Market Cap too high?
CVR Medical's current Market Cap is €1.52 Mil.
How does CVR Medical's Market Cap compare to NNMX and LHDXQ?
CVR Medical's Market Cap of €1.52 Mil can be compared against companies in the Medical Devices & Instruments industry. The industry median Market Cap is 112.48. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 112.48, based on 863 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on CVR Medical and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 112.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CVR Medical's current Market Cap is €1.52 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CVR Medical stock overvalued right now?
CVR Medical (STU:B3BN) has a current Market Cap of €1.52 Mil. The current Market Cap is €1.52 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For CVR Medical (STU:B3BN), the current Market Cap is €1.52 Mil as of Aug. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

CVR Medical Business Description

Address 221 West Esplanade, c/o Suite 409, North Vancouver, Vancouver, BC, CAN, V7M 3J3
CVR Medical Corp is a medical device company. The company commercializing its Carotid Stenotic Scan (CSS), a patented, diagnostic tool that utilizes subsonic, infrasonic, and low-frequency sound wave analysis technology to detect and measure carotid arterial stenosis.